Schedule 13G ownership disclosure

ACORDA THERAPEUTICS INC

Security class unavailable · CUSIP: 00484M106

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,821,426
Percent of class
14.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-20-000095
Form type
SC 13G
Filer
Acorda Therapeutics, Inc.
CIK
CIK 1008848
Filed
Jan 10, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub